ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CBX Cellular Goods Plc

0.375
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cellular Goods Plc LSE:CBX London Ordinary Share GB00BK964W87 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.375 0.35 0.40 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Catalog, Mail-order Houses 67k -3.31M -0.0055 -0.40 1.32M

Cellular Goods PLC Supply agreement signed with Willow Biosciences (4064B)

10/06/2021 7:00am

UK Regulatory


Cellular Goods (LSE:CBX)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Cellular Goods Charts.

TIDMCBX

RNS Number : 4064B

Cellular Goods PLC

10 June 2021

Press release

10 June 2021

Cellular Goods PLC

Multiyear supply agreement for cannabigerol (CBG) signed with Willow Biosciences

Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products based on lab-made cannabinoids, and Willow Biosciences Inc. ("Willow") (TSX: WLLW; OTCQX: CANSF), a biotechnology company producing ultra-pure, sustainably made compounds, are pleased to announce they have signed a multiyear supply agreement whereby Willow will supply Cellular Goods with its proprietary, ultra-pure, biosynthetically produced, cannabigerol ("Willow CBG") to be used in Cellular Goods' premium cannabinoid-based skin care products which launch in the autumn of 2021.

Willow's first shipment of Willow CBG to Cellular Goods will arrive in July this year.

In April 2021, Willow announced the completion of a series of studies with its development partner, Signum Biosciences, Inc., that demonstrate the safety and anti-inflammatory, anti-aging, and antimicrobial properties of Willow CBG on human skin. These results, coupled with the sustainable and safe manufacturing nature of Willow's manufacturing process, make Willow CBG an ideal core ingredient for cosmetics in the evolving regulatory landscape of the United Kingdom.

Last month the European Commission declared that cannabigerol (CBG) had been added to the EU cosmetic ingredients database (named "CosIng"), approving the compound as safe for use in personal care and cosmetics products. European manufacturers of personal care and cosmetics products can now use CBG in their products with the approval of a major market regulator for trade in the European Union. At present, the UK remains harmonised with CosIng.

Alexis Abraham, Cellular Goods' Chief Executive Officer, said: "Successful products start with the best ingredients and being able to source consistent, highly-pure cannabinoids via cellular agriculture from a trusted provider like Willow is essential to our business. CBG is the most promising cannabinoid for skincare applications and we believe it will become a must have upgrade to people's daily routines. Cellular Goods will be the first to bring a range to market in the UK built on our core principles of delivering efficacy-led and research-backed consumer cannabinoid products."

Trevor Peters, Willow's President & Chief Executive Officer, said: "We are very excited to announce our first commercial supply agreement for CBG. In just over two years we have gone from proof of concept in the lab to commercial scale up and sales of our first cannabinoid which will be slated for use in a consumer product. Cellular Goods are at the forefront of developing premium consumer cannabinoid products in the United Kingdom and we are thrilled to be supplying them with our ultra-pure, biosynthetically made CBG."

For further information please contact:

 
 Cellular Goods 
 Alexis Abraham                        +44 207 031 6871 
  Chief Executive 
  Neil Thapar 
  Investor Relations                    +44 787 645 5323 
                                      ------------------- 
 Tennyson Securities 
                                      ------------------- 
 Corporate Broker 
  Peter Krens                            +44 207 186 9030 
                                      ------------------- 
 Novum Securities 
                                      ------------------- 
 Corporate Broker 
  Colin Rowbury 
  Jon Belliss                            +44 207 399 9427 
                                      ------------------- 
 Tancredi Intelligent Communication 
                                      ------------------- 
 Media Relations 
  Helen Humphrey 
  Edward Daly                            +44 744 922 6720 
  Salamander Davoudi                     +44 786 143 0057 
  cellulargoods@tancredigroup.com        +44 795 754 9906 
                                      ------------------- 
 

About Cellular Goods PLC

Cellular Goods is a U.K.-based provider of premium consumer products based on biosynthetic cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid products. The initial focus is on two product verticals: premium skincare and topical athletic recovery products to be launched from this autumn. These will be made available through partnerships with leading online and physical retailers and direct to consumers through the Company's website.

www.cellulargoods.co

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company that develops and produces high-purity, plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. Willow's manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers. Willow's team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries.

www.willowbio.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGRFKLLBFQLEBBZ

(END) Dow Jones Newswires

June 10, 2021 02:00 ET (06:00 GMT)

1 Year Cellular Goods Chart

1 Year Cellular Goods Chart

1 Month Cellular Goods Chart

1 Month Cellular Goods Chart

Your Recent History

Delayed Upgrade Clock